The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.

For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. | For GSK CEO Emma Walmsley, ...

For Big Pharma CEOs, compensation can swing drastically year to year — from base salary to bonus incentives to stock options ...

UK drugmaker says Emma Walmsley is underpaid compared with global competitors as it abandons diversity targets ...

One of the lowest paid CEOs in pharma—and one of the only woman leading a top-tier giant—is set to receive up to $27.2 ...

Emma Walmsley has also been busy shaking up the company and has replaced 50 top managers, around 40% of the company’s management. Pfizer said in October that it is considering selling its ...

Dame Emma Walmsley prides herself on her tenacity. It is something the GSK chief says she inherited from her late father, a ...

Dame Emma Walmsley, chief executive of drugs giant GSK, received £10.6million in salary and bonuses in 2024 and under a new pay structure could receive as much as £21.6million for this year.

Since taking the helm in 2017, CEO Emma Walmsley has returned GSK to growth with a focus on cancer and infectious diseases to counter a combination of patent expiries and declining revenue from ...

British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale ...

GSK could double its long-serving CEO Emma Walmsley’s pay packet to £21.6 million ($27.2 million) after admitting its boss's current pay didn’t reward her performance and would put off future ...